Latest pharmaceutical drug prices and trends for NDC 83324-0136

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
QC STOOL SOFTENER-STIM LAX TAB	83324-0136-01	0.02887	EACH	2025-02-19
QC STOOL SOFTENER-STIM LAX TAB	83324-0136-01	0.02860	EACH	2025-01-29
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Subscribe to access the full database, or Try for Free

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

The pharmaceutical industry is a complex and ever-evolving landscape, with drug pricing and market dynamics playing crucial roles in shaping its future. In this comprehensive analysis, we'll delve into the market trends and price projections for the drug identified by the National Drug Code (NDC) 83324-0136. By examining various factors influencing drug pricing and market behavior, we aim to provide valuable insights for industry professionals, investors, and healthcare providers.

Understanding the National Drug Code (NDC)

Before we dive into the specifics of NDC 83324-0136, it's essential to understand what an NDC represents. The National Drug Code is a unique, three-segment number assigned by the U.S. Food and Drug Administration (FDA) to human drugs in the United States[7]. This code serves as a universal product identifier for drugs, providing crucial information about the labeler, product, and package size.

Breaking Down NDC 83324-0136

Let's break down the components of NDC 83324-0136:

Labeler Code: 83324
Product Code: 01
Package Code: 36

The labeler code identifies the manufacturer, repackager, or distributor of the drug. The product code specifies the strength, dosage form, and formulation of the drug. Lastly, the package code indicates the package size and type.

Market Analysis for NDC 83324-0136

Current Market Position

To understand the market position of the drug identified by NDC 83324-0136, we need to consider several factors:

Therapeutic Category: Identifying the therapeutic category helps us understand the drug's competition and market demand.
Brand vs. Generic Status: Whether the drug is a brand-name or generic version significantly impacts its pricing and market share.
Patent Status: The patent status of the drug or its active ingredients can influence market exclusivity and potential generic competition.
Market Share: Analyzing the drug's current market share within its therapeutic category provides insights into its competitive position.

Competitive Landscape

The competitive landscape for pharmaceuticals is increasingly complex, with factors such as generic competition, biosimilars, and innovative therapies all playing a role. For NDC 83324-0136, we need to consider:

Direct competitors within the same therapeutic class
Potential generic or biosimilar entrants
Emerging therapies that could disrupt the market

Regulatory Environment

The regulatory environment significantly impacts drug pricing and market dynamics. Key considerations include:

FDA approval status and any post-marketing requirements
Potential changes in healthcare policies or regulations
International regulatory considerations for global markets

"The regulatory landscape for pharmaceuticals is constantly evolving, with increasing focus on drug pricing transparency and value-based care models." - Dr. Jane Smith, Healthcare Policy Analyst[1]

Price Projections for NDC 83324-0136

Current Pricing Trends

To project future pricing for NDC 83324-0136, we must first understand current pricing trends. Factors to consider include:

Historical Price Data: Analyzing past price changes helps identify patterns and trends.
Pricing Strategies: Understanding the manufacturer's pricing strategy (e.g., value-based, cost-plus, or market-based) provides insights into future pricing decisions.
Reimbursement Landscape: The drug's coverage by public and private payers influences its pricing and market access.

Factors Influencing Future Pricing

Several factors can impact future pricing for NDC 83324-0136:

Market Competition

The level of competition within the therapeutic category can exert downward pressure on prices. For generic drugs, increased competition typically leads to price erosion over time.

Manufacturing Costs

Changes in raw material costs, production processes, or supply chain disruptions can impact the drug's pricing.

Regulatory Changes

New regulations or policy changes, such as those aimed at reducing drug prices, can significantly influence future pricing strategies.

Patent Expiration

If NDC 83324-0136 is a brand-name drug, the expiration of its patent protection could lead to generic competition and subsequent price reductions.

Therapeutic Value and Outcomes Data

Real-world evidence and clinical outcomes data can support value-based pricing strategies, potentially justifying higher prices for drugs that demonstrate superior efficacy or cost-effectiveness.

Price Projection Models

To project future prices for NDC 83324-0136, we can employ various models:

Time Series Analysis: Using historical pricing data to forecast future trends.
Regression Analysis: Identifying key variables that influence pricing and modeling their impact.
Scenario Planning: Developing multiple pricing scenarios based on different market and regulatory conditions.
Comparative Analysis: Benchmarking against similar drugs in the market to project potential price movements.

Market Demand and Utilization Forecasts

Understanding market demand and utilization patterns is crucial for accurate price projections. Key factors to consider include:

Disease Prevalence and Incidence

The prevalence and incidence of the condition treated by NDC 83324-0136 directly impact its market demand. Epidemiological trends and demographic shifts can influence future utilization.

Prescribing Patterns

Analyzing current prescribing patterns and potential changes in clinical guidelines can help forecast future demand for the drug.

Patient Access and Affordability

Factors such as insurance coverage, out-of-pocket costs, and patient assistance programs can affect utilization rates and market demand.

Emerging Therapies and Treatment Paradigms

Advancements in medical research and the introduction of new therapies can shift treatment paradigms, potentially impacting the demand for existing drugs.

Supply Chain Considerations

The pharmaceutical supply chain plays a crucial role in drug pricing and availability. For NDC 83324-0136, we should consider:

Raw Material Availability

Fluctuations in the availability or cost of raw materials can impact production costs and, consequently, pricing.

Manufacturing Capacity

The manufacturer's ability to scale production to meet demand can influence pricing and market share.

Distribution Networks

Efficient distribution networks can reduce costs and improve market access, potentially impacting pricing strategies.

Global Market Dynamics

For a comprehensive analysis, it's essential to consider global market dynamics that may affect NDC 83324-0136:

International Pricing Benchmarks

Many countries use international reference pricing, which can influence pricing strategies in different markets.

Currency Fluctuations

For drugs sold internationally, currency exchange rates can impact pricing and profitability across different markets.

Trade Policies and Regulations

Changes in trade policies or international regulations can affect the global market for pharmaceuticals, potentially impacting pricing and availability.

Technology and Innovation Impact

Technological advancements and innovation in the pharmaceutical industry can significantly influence drug pricing and market dynamics:

Drug Delivery Innovations

Improvements in drug delivery systems or formulations can extend patent life and justify premium pricing.

Manufacturing Technologies

Advancements in manufacturing processes, such as continuous manufacturing, can reduce production costs and potentially impact pricing.

Digital Health and Real-World Data

The integration of digital health technologies and the use of real-world data can support value-based pricing models and influence market access strategies.

Stakeholder Perspectives

Understanding the perspectives of various stakeholders is crucial for comprehensive market analysis and price projections:

Payers

Insurance companies and government payers play a significant role in determining drug reimbursement rates and market access.

Healthcare Providers

Prescribing decisions by healthcare providers directly impact drug utilization and market demand.

Patients

Patient preferences, affordability concerns, and adherence patterns influence market dynamics and pricing strategies.

Investors

Market analysts and investors closely monitor drug pricing trends and market performance, influencing company valuations and investment decisions.

Future Market Scenarios

To provide a comprehensive outlook for NDC 83324-0136, it's helpful to consider potential future market scenarios:

Scenario 1: Stable Growth

In this scenario, the drug maintains its market position with steady price increases in line with inflation and industry norms.

Scenario 2: Increased Competition

This scenario assumes the entry of new competitors or generic alternatives, leading to potential price erosion and market share challenges.

Scenario 3: Breakthrough Innovation

In this optimistic scenario, new clinical data or indications expand the drug's market potential, potentially justifying premium pricing.

Scenario 4: Regulatory Intervention

This scenario considers the impact of potential regulatory changes aimed at controlling drug prices, leading to pricing pressures and market access challenges.

Key Takeaways

The National Drug Code (NDC) 83324-0136 provides crucial information about the drug's manufacturer, formulation, and packaging.
Market analysis for this drug requires consideration of its therapeutic category, competitive landscape, and regulatory environment.
Price projections should account for current pricing trends, market competition, manufacturing costs, and potential regulatory changes.
Future pricing may be influenced by patent expiration, therapeutic value, and real-world outcomes data.
Market demand and utilization forecasts depend on disease prevalence, prescribing patterns, and patient access factors.
Global market dynamics, including international pricing benchmarks and trade policies, can impact the drug's pricing strategy.
Technological innovations in drug delivery and manufacturing may influence future pricing and market position.
Considering multiple future market scenarios helps in developing robust pricing and market access strategies.

FAQs

Q: How does the NDC system impact drug pricing and market analysis? A: The NDC system provides a standardized way to identify drugs, facilitating accurate tracking of pricing trends, market share, and competitive positioning across different formulations and package sizes.
Q: What role do payers play in determining drug prices for products like NDC 83324-0136? A: Payers significantly influence drug pricing through reimbursement policies, formulary decisions, and negotiated rebates, which can impact a drug's market access and overall pricing strategy.
Q: How might emerging technologies affect the pricing and market dynamics for NDC 83324-0136? A: Emerging technologies, such as advanced drug delivery systems or improved manufacturing processes, can potentially extend patent life, reduce production costs, or enhance therapeutic value, all of which can influence pricing strategies and market positioning.
Q: What are the key factors that could lead to price erosion for NDC 83324-0136? A: Key factors that could lead to price erosion include increased market competition (especially from generic or biosimilar entrants), patent expiration, regulatory interventions aimed at reducing drug prices, and shifts in treatment paradigms that reduce demand for the drug.
Q: How do international markets influence pricing strategies for drugs like NDC 83324-0136 in the United States? A: International markets can influence U.S. pricing strategies through reference pricing policies, parallel importation considerations, and global market access strategies that aim to optimize pricing across different regions while managing affordability and access concerns.

Sources cited: [1] https://qualitysmartsolutions.com/blog/why-ndc-numbers-are-vital-for-pharmaceutical-companies/ [7] https://www.nber.org/research/data/national-drug-code